Viewing Study NCT02304367


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-02-28 @ 2:28 PM
Study NCT ID: NCT02304367
Status: COMPLETED
Last Update Posted: 2024-05-06
First Post: 2014-11-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Sponsor: Kyowa Kirin, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-03-24
Start Date Type: ACTUAL
Primary Completion Date: 2017-07-27
Primary Completion Date Type: ACTUAL
Completion Date: 2021-01-21
Completion Date Type: ACTUAL
First Submit Date: 2014-11-24
First Submit QC Date: None
Study First Post Date: 2014-12-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-07-10
Results First Submit QC Date: None
Results First Post Date: 2020-07-30
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2018-07-20
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-05-02
Last Update Post Date: 2024-05-06
Last Update Post Date Type: ACTUAL